Company Profile

CartiCure Ltd. is an early-stage company dedicated to the development of innovative cartilage repair products. The Company is supported by the NGT High-Tech Incubator in Nazareth, Israel. Scientific work and on-going animal trials are being conducted at the Faculty of Medicine at the Technion-Institute of Technology in Haifa, Israel.

CartiCure’s technological platform generates original hyaline cartilage-producing cells to be transplanted into damaged joints; efficiently replenishing lesions in the articular cartilage. The Company’s first product, Cartimove© is designed for treatment of knee cartilage damage that results from trauma injuries. The Company’s next generation product is targeted at the Osteoarthritis market.

The Company has successfully completed pre-clinical studies performed in large and small animals, and is currently prepared to start human trials. It ahs a strong IP portfolio which includes a granted US patent.